Albireo Expands Leadership with Constantine Chinoporos as Chief Business OfficerGlobeNewsWire • 12/02/21
Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
Albireo Pharma (ALBO) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 10/28/21
Albireo Announces Exclusive Licensing Agreement with Jadeite Medicines for Bylvay™ (odevixibat) in JapanGlobeNewsWire • 10/12/21
Albireo and Genpharm Announce Agreement to Commercialize Bylvay™ (odevixibat) in Saudi Arabia and the Gulf RegionGlobeNewsWire • 08/18/21
Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/07/21